- Home
- FCUV vs TLPH Comparison
FCUV vs TLPH Comparison
Compare FCUV & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCUV
- TLPH
- Stock Information
- Founded
- FCUV 2012
- TLPH 2005
- Country
- FCUV United States
- TLPH United States
- Employees
- FCUV N/A
- TLPH N/A
- Industry
- FCUV Industrial Machinery/Components
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- FCUV Industrials
- TLPH Health Care
- Exchange
- FCUV Nasdaq
- TLPH Nasdaq
- Market Cap
- FCUV 15.9M
- TLPH 11.1M
- IPO Year
- FCUV N/A
- TLPH 2011
- Fundamental
- Price
- FCUV $2.80
- TLPH $0.93
- Analyst Decision
- FCUV
- TLPH Strong Buy
- Analyst Count
- FCUV 0
- TLPH 1
- Target Price
- FCUV N/A
- TLPH $6.00
- AVG Volume (30 Days)
- FCUV 64.2K
- TLPH 7.3M
- Earning Date
- FCUV 11-06-2025
- TLPH 11-12-2025
- Dividend Yield
- FCUV N/A
- TLPH N/A
- EPS Growth
- FCUV N/A
- TLPH N/A
- EPS
- FCUV N/A
- TLPH N/A
- Revenue
- FCUV $432,983.00
- TLPH $27,000.00
- Revenue This Year
- FCUV N/A
- TLPH N/A
- Revenue Next Year
- FCUV N/A
- TLPH $14,533.26
- P/E Ratio
- FCUV N/A
- TLPH N/A
- Revenue Growth
- FCUV 140.82
- TLPH N/A
- 52 Week Low
- FCUV $1.80
- TLPH $0.38
- 52 Week High
- FCUV $10.90
- TLPH $1.20
- Technical
- Relative Strength Index (RSI)
- FCUV 64.48
- TLPH 79.40
- Support Level
- FCUV $2.06
- TLPH $0.40
- Resistance Level
- FCUV $3.18
- TLPH $1.07
- Average True Range (ATR)
- FCUV 0.25
- TLPH 0.13
- MACD
- FCUV 0.13
- TLPH 0.05
- Stochastic Oscillator
- FCUV 72.73
- TLPH 61.44
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.